14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 ADXS stock ended at $0.531. This is 3.55% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 0% from a day low at $0.531 to a day high of $0.531.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Advaxis prices

Date Open High Low Close Volume
Dec 17, 2020 $0.317 $0.325 $0.311 $0.313 2 446 511
Dec 16, 2020 $0.330 $0.330 $0.305 $0.314 5 691 754
Dec 15, 2020 $0.330 $0.332 $0.313 $0.330 3 564 493
Dec 14, 2020 $0.340 $0.349 $0.324 $0.327 4 116 330
Dec 11, 2020 $0.322 $0.350 $0.317 $0.332 6 329 892
Dec 10, 2020 $0.317 $0.333 $0.312 $0.321 5 426 666
Dec 09, 2020 $0.316 $0.319 $0.294 $0.315 6 693 481
Dec 08, 2020 $0.320 $0.330 $0.313 $0.322 4 662 745
Dec 07, 2020 $0.360 $0.362 $0.312 $0.320 9 942 313
Dec 04, 2020 $0.332 $0.350 $0.320 $0.340 9 854 297
Dec 03, 2020 $0.320 $0.345 $0.310 $0.337 14 517 502
Dec 02, 2020 $0.302 $0.325 $0.291 $0.312 9 212 871
Dec 01, 2020 $0.310 $0.330 $0.310 $0.317 15 711 462
Nov 30, 2020 $0.287 $0.295 $0.280 $0.295 10 989 283
Nov 27, 2020 $0.300 $0.308 $0.272 $0.285 8 475 385
Nov 25, 2020 $0.293 $0.298 $0.280 $0.288 14 281 902
Nov 24, 2020 $0.265 $0.289 $0.264 $0.284 44 472 465
Nov 23, 2020 $0.380 $0.392 $0.370 $0.391 2 026 519
Nov 20, 2020 $0.371 $0.395 $0.370 $0.385 879 221
Nov 19, 2020 $0.390 $0.390 $0.376 $0.388 1 065 675
Nov 18, 2020 $0.398 $0.399 $0.375 $0.382 923 989
Nov 17, 2020 $0.393 $0.400 $0.383 $0.393 707 635
Nov 16, 2020 $0.400 $0.405 $0.382 $0.395 1 131 128
Nov 13, 2020 $0.394 $0.407 $0.381 $0.400 998 700
Nov 12, 2020 $0.413 $0.420 $0.390 $0.394 1 123 428
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT